1 not yet recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Not yet recruiting 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow TUB-040 - RP2D: new trials by email Literature Review of TUB-040 - RP2D trials Research Report on TUB-040 - RP2D
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of TUB-040 in Patients With Recurrent or Progressive Uterine Cancer After Chemotherapy and Immune Therapy TUB-040 - Dose escalation, TUB-040 - RP2D - Uterine Endometrial Cancer | Phase 1 / Phase 2 | Not yet recruiting | Gilead Sciences | 100 | 2026-10-01 | 2026-08-05 |
Gilead Sciences (1)
United States (1)